---
title: "Why top 3% biotech stock, Eton, just catapulted to a record high"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295950325.md"
description: "Eton stock catapulted to a record high Friday after the biotech company smashed second-quarter sales forecasts and hiked its guidance."
datetime: "2026-08-14T14:52:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295950325.md)
  - [en](https://longbridge.com/en/news/295950325.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295950325.md)
---

# Why top 3% biotech stock, Eton, just catapulted to a record high

Eton stock catapulted to a record high Friday after the biotech company smashed second-quarter sales forecasts and hiked its guidance.

### Related Stocks

- [ETON.US](https://longbridge.com/en/quote/ETON.US.md)

## Related News & Research

- [ETON: Record Q2 revenue and raised 2026 guidance reflect strong rare disease portfolio momentum](https://longbridge.com/en/news/295841094.md)
- [Eton Pharma COO Danka Radosavljevic files initial beneficial ownership statement](https://longbridge.com/en/news/295709440.md)
- [MeiraGTx (MGTX) Stock Jumps After Profit Shock Raises Durability Questions](https://longbridge.com/en/news/295983782.md)
- [Dianthus Therapeutics (DNTH) Climbed, What Is Behind The Move?](https://longbridge.com/en/news/295760929.md)
- [Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) Director Sells $167,152.80 in Stock](https://longbridge.com/en/news/295589663.md)